These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19595597)

  • 1. Antimicrobial natural products as beta-ketoacyl-acyl carrier protein synthase III inhibitors.
    Lee JY; Jeong KW; Shin S; Lee JU; Kim Y
    Bioorg Med Chem; 2009 Aug; 17(15):5408-13. PubMed ID: 19595597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel E. coli beta-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics.
    Lee JY; Jeong KW; Lee JU; Kang DI; Kim Y
    Bioorg Med Chem; 2009 Feb; 17(4):1506-13. PubMed ID: 19185501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel selective inhibitors of Staphylococcus aureus β-ketoacyl acyl carrier protein synthase III.
    Lee JY; Jeong KW; Shin S; Lee JU; Kim Y
    Eur J Med Chem; 2012 Jan; 47(1):261-9. PubMed ID: 22104972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents.
    Nie Z; Perretta C; Lu J; Su Y; Margosiak S; Gajiwala KS; Cortez J; Nikulin V; Yager KM; Appelt K; Chu S
    J Med Chem; 2005 Mar; 48(5):1596-609. PubMed ID: 15743201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target Proteins of Phloretin for Its Anti-Inflammatory and Antibacterial Activities Against
    Cheon D; Kim J; Jeon D; Shin HC; Kim Y
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30987239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics.
    Li HQ; Shi L; Li QS; Liu PG; Luo Y; Zhao J; Zhu HL
    Bioorg Med Chem; 2009 Sep; 17(17):6264-9. PubMed ID: 19664929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
    Lv PC; Wang KR; Yang Y; Mao WJ; Chen J; Xiong J; Zhu HL
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6750-4. PubMed ID: 19836235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel deoxyribofuranosyl indole antimicrobial agents.
    Paudel A; Hamamoto H; Kobayashi Y; Yokoshima S; Fukuyama T; Sekimizu K
    J Antibiot (Tokyo); 2012 Feb; 65(2):53-7. PubMed ID: 22167161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The crystal structure of beta-ketoacyl-acyl carrier protein synthase II from Synechocystis sp. at 1.54 A resolution and its relationship to other condensing enzymes.
    Moche M; Dehesh K; Edwards P; Lindqvist Y
    J Mol Biol; 2001 Jan; 305(3):491-503. PubMed ID: 11152607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Li HQ; Luo Y; Zhu HL
    Bioorg Med Chem; 2011 Aug; 19(15):4454-9. PubMed ID: 21742506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of flavonoids as candidate antibiotics against Enterococcus faecalis.
    Jeong KW; Lee JY; Kang DI; Lee JU; Shin SY; Kim Y
    J Nat Prod; 2009 Apr; 72(4):719-24. PubMed ID: 19236029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a scintillation proximity assay for the Mycobacterium tuberculosis KasA and KasB enzymes involved in mycolic acid biosynthesis.
    Schaeffer ML; Carson JD; Kallender H; Lonsdale JT
    Tuberculosis (Edinb); 2004; 84(6):353-60. PubMed ID: 15525558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antibacterial activities and molecular docking studies of peptide and Schiff bases as targeted antibiotics.
    Cheng K; Zheng QZ; Qian Y; Shi L; Zhao J; Zhu HL
    Bioorg Med Chem; 2009 Dec; 17(23):7861-71. PubMed ID: 19884012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents.
    Shi L; Fang RQ; Zhu ZW; Yang Y; Cheng K; Zhong WQ; Zhu HL
    Eur J Med Chem; 2010 Sep; 45(9):4358-64. PubMed ID: 20557983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combined approach of docking and 3D QSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Ashek A; Cho SJ
    Bioorg Med Chem; 2006 Mar; 14(5):1474-82. PubMed ID: 16275103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiolactomycin-Based Inhibitors of Bacterial β-Ketoacyl-ACP Synthases with in Vivo Activity.
    Bommineni GR; Kapilashrami K; Cummings JE; Lu Y; Knudson SE; Gu C; Walker SG; Slayden RA; Tonge PJ
    J Med Chem; 2016 Jun; 59(11):5377-90. PubMed ID: 27187871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
    Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical characterization of 3-ketoacyl-acyl carrier protein synthase II from leek epidermis.
    Domergue F; Post-Beittenmiller D
    Biochem Soc Trans; 2000 Dec; 28(6):610-3. PubMed ID: 11171142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A template search reveals mechanistic similarities and differences in beta-ketoacyl synthases (KAS) and related enzymes.
    Dawe JH; Porter CT; Thornton JM; Tabor AB
    Proteins; 2003 Aug; 52(3):427-35. PubMed ID: 12866053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty acid synthesis. Role of active site histidines and lysine in Cys-His-His-type beta-ketoacyl-acyl carrier protein synthases.
    von Wettstein-Knowles P; Olsen JG; McGuire KA; Henriksen A
    FEBS J; 2006 Feb; 273(4):695-710. PubMed ID: 16441657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.